Ifinatamab

• CAS Number :

  2484870-90-6

• Target :

  Immunology/Inflammation related|||B7|||Integrin

• Related Pathways :

  Immunology/Inflammation|||Cytoskeletal Signaling

• Purity :

  0.991

• Bioactivity :

  Ifinatamab is a humanised monoclonal immunoglobulin that targets and inhibits the B7-H3 protein. Ifinatamab can be used to synthesise the ADC drug Ifinatamab deruxtecan for the treatment of small cell lung cancer (SCLC) .

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C